Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease

Autor: Chen, Yi-Bin 1, ∗, Perales, Miguel-Angel 2, 3, Li, Shuli 4, Kempner, Maria 1, Reynolds, Carol 5, Brown, Jami 1, Efebera, Yvonne A. 6, Devine, Steven M. 6, El-Jawahri, Areej 1, McAfee, Steven L. 1, Spitzer, Thomas R. 1, Soiffer, Robert J. 5, Ritz, Jerome 5, Cutler, Corey 5
Zdroj: In Blood 15 June 2017 129(24):3256-3261
Databáze: ScienceDirect